Steminent Biotherapeutics, Inc (TPEX:7729)

Market Cap	1.53B
Revenue	n/a
Net Income	n/a
Shares Out	56.11M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	380,874
Average Volume	288,858
Open	27.35
Previous Close	27.30
Day's Range	24.90 - 27.50
52-Week Range	15.25 - 30.30
Beta	n/a
RSI	60.69
Earnings Date	n/a

About Steminent Biotherapeutics

Steminent Biotherapeutics, Inc., a stem cell research and development company, develops and manufactures novel cellular therapeutics for the treatment of diseases with unmet or under-served medical needs. The company focuses on Stemchymal portfolio of cell therapy research and development programs based on allogeneic stem cells that target neurodegenerative and other degenerative diseases. Its product pipeline includes various pre-clinical and clinical stage therapeutic programs for the treatment of spinocerebellar ataxia (PolyQ SCA), osteoarth...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2009
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 7729